Agonists and antagonists
An agonist is a drug that binds to a receptor and activates it, mimicking the body's natural signaling molecule. An antagonist binds the same receptor but produces no response, blocking the natural molecule from acting.
Most drugs work by interacting with receptors — proteins on or inside cells that trigger a biological response when activated. An agonist binds a receptor and switches it on, imitating the body's own chemical messenger. An antagonist occupies the receptor without activating it, acting as a blocker that prevents agonists and natural messengers from producing their effect.
Agonists vary in strength. A full agonist produces the receptor's maximum possible response, while a partial agonist activates the receptor but can never reach that maximum, no matter the dose. Antagonists differ in how they block: a competitive antagonist binds the same site as the agonist and can be overcome by higher agonist concentrations, while a noncompetitive antagonist binds elsewhere or irreversibly, reducing the maximum response an agonist can achieve.
The classic clinical pairing is the opioids: morphine is an opioid receptor agonist that produces analgesia, while naloxone is an opioid antagonist that reverses an overdose by displacing the agonist from its receptors. The same logic runs through beta-blockers, antihistamines, antipsychotics, and countless other drug classes — understanding whether a drug turns a receptor on or blocks it predicts both its therapeutic effect and its side effects.
USMLE Step 1 tests agonist and antagonist pharmacodynamics in depth, including dose-response curves and how competitive versus noncompetitive blockade shifts them. The PTCE draws on the same receptor concepts when covering drug classes and their mechanisms. Know the definitions, the full-versus-partial agonist distinction, and the morphine–naloxone example.
Key takeaways
- Agonists activate receptors; antagonists occupy receptors without activating them, blocking the response.
- Full agonists produce the maximum receptor response; partial agonists cannot, regardless of dose.
- Competitive antagonists can be overcome by more agonist; noncompetitive antagonists lower the achievable maximum response.
- Morphine (agonist) and naloxone (antagonist) at opioid receptors are the classic clinical example.
- USMLE Step 1 and the PTCE test these pharmacodynamic concepts and their dose-response consequences.